The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Open accessAbstract
BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) is an allergen-mediated inflammatory disease with no approved treatment in the United States. Dupilumab, a VelocImmune-derived human monoclonal antibody against the interleukin (IL) 4 receptor, inhibits IL4 and IL13 signaling. Dupilumab is effective in the treatment of allergic, atopic, and type 2 diseases, so we assessed its efficacy and safety in patients with EoE. METHODS: We performed a phase 2 study of adults with active EoE (2 episodes of dysphagia/week with peak esophageal eosinophil density of 15 or more eosinophils per high-power field), from May 12, 2015, through November 9, 2016, at 14 sites. Participants were randomly assigned to groups that received weekly subcutaneous injections of dupilumab (300 mg, n = 23) or placebo (n = 24) for 12 weeks. The primary endpoint was change from baseline to week 10 in Straumann Dysphagia Instrument (SDI) patient-reported outcome (PRO) score. We also assessed histologic features of EoE (peak esophageal intraepithelial eosinophil count and EoE histologic scores), endoscopically visualized features (endoscopic reference score), esophageal distensibility, and safety. RESULTS: The mean SDI PRO score was 6.4 when the study began. In the dupilumab group, SDI PRO scores were reduced by a mean value of 3.0 at week 10 compared with a mean reduction of 1.3 in the placebo group (P = .0304). At week 12, dupilumab reduced the peak esophageal intraepithelial eosinophil count by a mean 86.8 eosinophils per high-power field (reduction of 107.1%; P < .0001 vs placebo), the EoE-histologic scoring system (HSS) severity score by 68.3% (P < .0001 vs placebo), and the endoscopic reference score by 1.6 (P = .0006 vs placebo). Dupilumab increased esophageal distensibility by 18% vs placebo (P < .0001). Higher proportions of patients in the dupilumab group developed injection-site erythema (35% vs 8% in the placebo group) and nasopharyngitis (17% vs 4% in the placebo group). CONCLUSIONS: In a phase 2 trial of patients with active EoE, dupilumab reduced dysphagia, histologic features of disease (including eosinophilic infiltration and a marker of type 2 inflammation), and abnormal endoscopic features compared with placebo. Dupilumab increased esophageal distensibility and was generally well tolerated. ClinicalTrials.gov, Number: NCT02379052.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Self-citationEosinophilic esophagitis: Updated consensus recommendations for children and adults
Liacouras, C. A., Furuta, G. T., Hirano, I., Atkins, D., Attwood, S. E., Bonis, P. A., Burks, A. W., Chehade, M., Collins, M. H., Dellon, E. S., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.040 · Cited by 2,073
Self-citationDupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Self-citationBlauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261
Self-citationEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Rabe, K. F., Nair, P., Brusselle, G., Maspero, J. F., Castro, M., Sher, L., Zhu, H., Hamilton, J. D., Swanson, B. N., Khan, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804093 · Cited by 1,184
Self-citationDellon, E. S., Gonsalves, N., Hirano, I., Furuta, G. T., Liacouras, C. A., & Katzka, D. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.71 · Cited by 1,159
Self-citationWenzel, S., Castro, M., Corren, J., Maspero, J., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E. R., Evans, R. R., Joish, V. N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30307-5 · Cited by 985
Self-citationHirano, I., Moy, N., Heckman, M. G., Thomas, C. S., Gonsalves, N., & Achem, S. R. (2013) · Gut · doi:10.1136/gutjnl-2011-301817 · Cited by 945
Self-citationBachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794
Self-citationEpidemiology and Natural History of Eosinophilic Esophagitis
Dellon, E. S., & Hirano, I. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.06.067 · Cited by 781
Self-citationStraumann, A., Conus, S., Grzonka, P., Kita, H., Kephart, G., Bussmann, C., Beglinger, C., Smith, D. A., Patel, J., Byrne, M., et al. (2010) · Gut · doi:10.1136/gut.2009.178558 · Cited by 598
Thaçi, D., Simpson, E. L., Beck, L. A., Bieber, T., Blauvelt, A., Papp, K., Soong, W., Worm, M., Szepietowski, J. C., Sofen, H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00388-8 · Cited by 572
Self-citationSpergel, J. M., Rothenberg, M. E., Collins, M. H., Furuta, G. T., Markowitz, J. E., Fuchs, G., O’Gorman, M. A., Abonia, J. P., Young, J., Henkel, T., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.044 · Cited by 556
Self-citationFuruta, G. T., & Katzka, D. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1502863 · Cited by 549
Budesonide Is Effective in Adolescent and Adult Patients With Active Eosinophilic Esophagitis
Straumann, A., Conus, S., Degen, L., Felder, S., Kummer, M., Engel, H., Bussmann, C., Beglinger, C., Schoepfer, A., & Simon, H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.048 · Cited by 524
Self-citationPathophysiology of Eosinophilic Esophagitis
O’Shea, K. M., Aceves, S. S., Dellon, E. S., Gupta, S. K., Spergel, J. M., Furuta, G. T., & Rothenberg, M. E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.06.065 · Cited by 502
Self-citationCommonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
Self-citationEosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
Clayton, F., Fang, J. C., Gleich, G. J., Lucendo, A. J., Olalla, J. M., Vinson, L. A., Lowichik, A., Chen, X., Emerson, L., Cox, K., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.036 · Cited by 492
Self-citationMurphy, A. J., Macdonald, L. E., Stevens, S., Karow, M., Dore, A. T., Pobursky, K., Huang, T. T., Poueymirou, W. T., Esau, L., Meola, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324022111 · Cited by 455
Self-citationAssa'ad, A. H., Gupta, S. K., Collins, M. H., Thomson, M., Heath, A. T., Smith, D. A., Perschy, T. L., Jurgensen, C. H., Ortega, H. G., & Aceves, S. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.044 · Cited by 435
Self-citationArias, Á., Pérez‐Martínez, I., Tenías, J. M., & Lucendo, A. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13441 · Cited by 413
Collins, M. H., Martin, L. J., Alexander, E. S., Boyd, J. T., Sheridan, R., He, H., Pentiuk, S., Putnam, P. E., Abonia, J. P., Mukkada, V. A., et al. (2016) · Diseases of the Esophagus · doi:10.1111/dote.12470 · Cited by 402
Self-citationPrecise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
Macdonald, L. E., Karow, M., Stevens, S., Auerbach, W., Poueymirou, W. T., Yasenchak, J., Frendewey, D., Valenzuela, D. M., Giallourakis, C. C., Alt, F. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323896111 · Cited by 391
Self-citationSafroneeva, E., Straumann, A., Coslovsky, M., Zwahlen, M., Kuehni, C. E., Panczak, R., Haas, N. A., Alexander, J. A., Dellon, E. S., Gonsalves, N. P., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.004 · Cited by 347
Self-citationEpidemiology of Eosinophilic Esophagitis
Dellon, E. S. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.02.002 · Cited by 304
Self-citationSchoepfer, A. M., Straumann, A., Panczak, R., Coslovsky, M., Kuehni, C. E., Maurer, E., Haas, N. A., Romero, Y., Hirano, I., Alexander, J. A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.028 · Cited by 289
Self-citationMolecular, Genetic, and Cellular Bases for Treating Eosinophilic Esophagitis
Rothenberg, M. E. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.002 · Cited by 210
Self-citationMukkada, V., Falk, G. W., Eichinger, C. S., King, D., Todorova, L., & Shaheen, N. J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.036 · Cited by 164
Self-citationTaft, T., Kern, E. M., Kwiatek, M. A., Hirano, I., Gonsalves, N. P., & Keefer, L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04791.x · Cited by 142
Self-citationClinical Implications and Pathogenesis of Esophageal Remodeling in Eosinophilic Esophagitis
Hirano, I., & Aceves, S. S. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.02.015 · Cited by 138
Self-citationQualitative Assessment of Patient-reported Outcomes in Adults With Eosinophilic Esophagitis
Taft, T., Kern, E. M., Keefer, L., Burstein, D., & Hirano, I. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182166a5a · Cited by 93
Self-citation
Cited by
Le Floc’h, A., Allinne, J., Nagashima, K., Scott, G., Birchard, D., Asrat, S., Bai, Y., Lim, W. K., Martin, J., Huang, T., et al. (2020) · Allergy · doi:10.1111/all.14151 · Cited by 545
Self-citationSimpson, E. L., Paller, A. S., Siegfried, E. C., Boguniewicz, M., Sher, L., Gooderham, M. J., Beck, L. A., Guttman-Yassky, E., Pariser, D., Blauvelt, A., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.3336 · Cited by 524
Self-citationDupilumab in Adults and Adolescents with Eosinophilic Esophagitis
Dellon, E. S., Rothenberg, M. E., Collins, M. H., Hirano, I., Chehade, M., Bredenoord, A. J., Lucendo, A. J., Spergel, J. M., Aceves, S., Sun, X., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205982 · Cited by 484
Self-citationChronic Rhinosinusitis with Nasal Polyps and Asthma
Laidlaw, T. M., Mullol, J., Woessner, K. M., Amin, N., & Mannent, L. P. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.09.063 · Cited by 419
Self-citationHirano, I., Chan, E. S., Rank, M. A., Sharaf, R. N., Stollman, N. H., Stukus, D. R., Wang, K., Greenhawt, M., Falck-Ytter, Y. T., Chachu, K. A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.038 · Cited by 329
Self-citation
Metadata
- Authors
- Hirano, I., Dellon, E. S., Hamilton, J. D., Collins, M. H., Peterson, K., Chehade, M., Schoepfer, A. M., Safroneeva, E., Rothenberg, M. E., Falk, G. W., Assouline-Dayan, Y., Zhao, Q., Chen, Z., Swanson, B. N., Pirozzi, G., Mannent, L., Graham, N. M. H., Akinlade, B., Stahl, N., Yancopoulos, G. D., & Radin, A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 158
- Issue
- 1
- Pages
- 111-122.e10
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2978440834
- Cited by
- 460
- References
- 31
- FWCI
- 49.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.